Application of reference-scaled criteria for AUC in bioequivalence studies conducted for submission to PQT/MED
WHO bioequivalence guidelines (TRS No.
First dolutegravir 5mg dispersible tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First darunavir/ritonavir tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lab Liconsa’s ivermectin prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Naari’s levonorgestrel tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Panpharma’s oxytocin injection prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Tunggal’s medroxyprogesterone acetate depot injection prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Macleods’ dispersible sulfadoxine/pyrimethamine tablet prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New Invitation for Expression of Interest (EOI) to manufacturers of antituberculosis medicines published
The Invitation to Manufacturers of Antituberculosis Medicines to submit an Expression of Interest for Product Evaluation to the WHO Prequalification Unit was recently updated following a request by